P-glycoprotein expression in human cerebral malaria: a preliminary study

1. Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385-427.10.1146/annurev.bi.62.070193.002125Open DOISearch in Google Scholar

2. Persidis A. Cancer multidrug resistance. Nat Biotechnol. 1999; 17:94-5.10.1038/5289Open DOISearch in Google Scholar

3. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A. 1987; 84:265-9.10.1073/pnas.84.1.265Open DOISearch in Google Scholar

4. Callaghan R, Crowley E, Potter S, Kerr ID. P-glycoprotein: so many ways to turn it on. J Clin Pharmacol. 2008; 48:365-78.10.1177/0091270007311568Open DOISearch in Google Scholar

5. Miller DS, Bauer B, Hartz AM. Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. Pharmacol Rev. 2008; 60:196-209.10.1124/pr.107.07109Open DOISearch in Google Scholar

6. Sein KK, Maeno Y, Thuc HV, Anh TK, Aikawa M. Differential sequestration of parasitized erythrocytes in the cerebrum and cerebellum in human cerebral malaria. Am J Trop Med Hyg. 1993; 48:504-11.10.4269/ajtmh.1993.48.504Search in Google Scholar

7. Kochar DK, Kumawat BL, Halwai M, Kochar SK, Shubhakaran, Thanvi I. Brainstem auditory evoked potentials and somatosensory evoked potentials in cerebral malaria-a prognostic significance. J Assoc Physicians India. 2000; 48:295-300.Search in Google Scholar

8. Chaudhary HR, Meena SR, Jani D, Tiwari U, Goyal RK. Extrapyramidal syndrome in cerebral malaria. J Assoc Physicians India. 1992; 40:347.Search in Google Scholar

9. Clark CJ, Phillips RS, Stone TW. Neuropeptidecontaining cells in the cortex and striatum of mice with cerebral malaria. Adv Exp Med Biol. 2003; 527: 347-52.10.1007/978-1-4615-0135-0_38Search in Google Scholar

10. Newton CR, Warrell DA. Neurological manifestations of falciparum malaria. Ann Neurol. 1998; 43:695-702.10.1002/ana.410430603Open DOISearch in Google Scholar

11. Berendt AR, Tumer GD, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994; 10:412-4.10.1016/0169-4758(94)90238-0Open DOISearch in Google Scholar

12. Brown H, Turner G, Rogerson S, Tembo M, Mwenechanya J, Molyneux M, et al. Cytokine expression in the brain in human cerebral malaria. J Infect Dis. 1999; 180:1742-6.10.1086/31507810515846Search in Google Scholar

13. Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, et al. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol. 1999; 25:331-40.10.1046/j.1365-2990.1999.00188.xOpen DOISearch in Google Scholar

14. Abbott NJ, Hughes CC, Revest PA, Greenwood J. Development and characterisation of a rat brain capillary endothelial culture: towards an in vitro blood-brain barrier. J Cell Sci. 1992; 103:23-37.10.1242/jcs.103.1.23Search in Google Scholar

15. Hong H, Lu Y, Ji ZN, Liu GQ. Up-regulation of P-glycoprotein expression by glutathione depletioninduced oxidative stress in rat brain microvessel endothelial cells. J Neurochem. 2006; 98:1465-73.10.1111/j.1471-4159.2006.03993.xOpen DOISearch in Google Scholar

16. Dorovini-Zis K, Schmidt K, Huynh H, Fu W, Whitten RO, Milner D, et al. The neuropathology of fatal cerebral malaria in Malawian children. Am J Pathol. 2011; 178:2146-58.10.1016/j.ajpath.2011.01.016Search in Google Scholar

17. Idro R, Kakooza-Mwesige A, Balyejjussa S, Mirembe G, Mugasha C, Tugumisirize J, et al. Severe neurological sequelae and behaviour problems after cerebral malaria in Ugandan children. BMC Res Notes. 2010; 3:104.10.1186/1756-0500-3-104Open DOISearch in Google Scholar

18. Kooij G, van Horssen J, de Lange EC, Reijerkerk A, van der Pol SM, van Het Hof B, et al. T lymphocytes impair P-glycoprotein function during neuroinflammation. J Autoimmun. 2010; 34:416-25.10.1016/j.jaut.2009.10.006Open DOISearch in Google Scholar

19. McRae MP, Brouwer KL, Kashuba AD. Cytokine regulation of P-glycoprotein. Drug Metab Rev. 2003; 35:19-33.10.1081/DMR-120018247Open DOISearch in Google Scholar

20. Goralski KB, Hartmann G, Piquette-Miller M, Renton KW. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br J Pharmacol. 2003; 139: 35-48.10.1038/sj.bjp.0705227Search in Google Scholar

21. Zhao YL, Du J, Kanazawa H, Sugawara A, Takagi K, Kitaichi K, et al. Effect of endotoxin on doxorubicin transport across blood-brain barrier and Pglycoprotein function in mice. Eur J Pharmacol. 2002; 445:115-23.10.1016/S0014-2999(02)01661-8Search in Google Scholar

22. Tan KH, Purcell WM, Heales SJ, McLeod JD, Hurst RD. Evaluation of the role of P-glycoprotein in inflammation induced blood-brain barrier damage. Neuroreport. 2002; 13:2593-7.10.1097/00001756-200212200-0004212499874Open DOISearch in Google Scholar

23. Theron D, Barraud de Lagerie S, Tardivel S, Pelerin H, Demeuse P, Mercier C, et al. Influence of tumor necrosis factor-á on the expression and function of P-glycoprotein in an immortalised rat brain capillary endothelial cell line, GPNT. Biochem Pharmacol. 2003; 66:579-87.10.1016/S0006-2952(03)00340-XOpen DOISearch in Google Scholar

24. Walther W, Stein U. Influence of cytokines on mdr1 expression in human colon carcinoma cell lines: increased cytotoxicity of MDR relevant drugs. J Cancer Res Clin Oncol. 1994; 120:471-8.10.1007/BF011918008207045Open DOISearch in Google Scholar

25. Yu C, Kastin AJ, Tu H, Waters S, Pan W. TNF activates P-glycoprotein in cerebral microvascular endothelial cells. Cell Physiol Biochem. 2007; 20:853-8.10.1159/00011044517982267Open DOISearch in Google Scholar

26. Kooij G, Backer R, Koning JJ, Reijerkerk A, van Horssen J, van der Pol SM, et al. P-glycoprotein acts as an immunomodulator during neuroinflammation. PLoS One. 2009; 4:e8212. 10.1371/journal.pone.0008212278547919997559Open DOISearch in Google Scholar